by The global nerve repair and regeneration market size was valued at US$ 9.8 billion in 2021 and is anticipated to grow US$ 24.9 billion by 2030, registering a compound annual growth rate of 10.92% from 2022 to 2030.
The nerve repair and regeneration market report covering various industry elements and growth trends helpful for predicting the market’s future.
The study provides a strong base for the nerve repair and regeneration market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2030.
This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2022 to 2030. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the nerve repair and regeneration report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the nerve repair and regeneration market have been studied and analysed across many developments.
Nerve Repair and Regeneration Market Report Scope
| Report Coverage | Details |
| Market Size in 2022 | USD 10.87 Billion |
| Market Size by 2030 | USD 24.9 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 10.92% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered |
|
Also read: High Potency Active Pharmaceutical Ingredients Market Size to Grow US$ 53.8 Billion By 2030
Research Approach
The comprehensive report on the global nerve repair and regeneration market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global nerve repair and regeneration market.
It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Key Players
- Medtronic, plc. (Ireland)
- Boston Scientific Corporation (US)
- Abbott Laboratories (US)
- Axogen Corporation (US)
- Baxter (US)
- LivaNova PLC (UK)
- Integra LifeSciences (US)
- Neuronetics Inc. (US)
- Nevro Corp (US)
- NeuroPace Inc. (US)
- Polyganics (Netherlands)
- Soterix Medical Inc (US)
- Synapse Biomedical Inc. (US)
- Aleva Neurotherapeutics SA (Switzerland)
- Collagen Matrix Inc. (US)
- KeriMedical
- (Switzerland), BioWaveGO USA (US)
- NeuroSigma Inc. (US)
- tVNS Technologies GmbH (Germany)
- GiMer Medical (Taiwan)
- Checkpoint Surgical Inc.
- (US), Renishaw PLC (UK)
- Alafair Biosciences, Inc. (US)
- electroCore, Inc. (US).
Nerve Repair and Regeneration Market Segmentations
By Product
- Biomaterials
- Nerve Conduits
- Nerve Wraps
- Neurostimulation and Neuromodulation Devices
- Spinal Cord Stimulation Devices
- Sacral Nerve Stimulation Devices
- Deep Brain Stimulation Devices
- Vagus Nerve Stimulation Devices
- Gastric Electric Stimulation Devices
By Application
- Direct Nerve Repair/Neurorrhaphy
- Epineural Repair
- Perineural Repair
- Group Fascicular Repair
- Stem Cell Therapy
- Nerve Grafting
- Autografts
- Allografts
- Xenografts
- Neurostimulation and Neuromodulation Surgeries
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Nerve Repair and Regeneration Market
5.1. COVID-19 Landscape: Nerve Repair and Regeneration Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Nerve Repair and Regeneration Market, By Product
8.1. Nerve Repair and Regeneration Market, by Product, 2022-2030
8.1.1. Biomaterials
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Neurostimulation and Neuromodulation Devices
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Nerve Repair and Regeneration Market, By Application
9.1. Nerve Repair and Regeneration Market, by Application, 2022-2030
9.1.1. Direct Nerve Repair/Neurorrhaphy
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Stem Cell Therapy
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Nerve Grafting
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Neurostimulation and Neuromodulation Surgeries
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Nerve Repair and Regeneration Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
Chapter 11. Company Profiles
11.1. Medtronic, plc. (Ireland)
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Boston Scientific Corporation (US)
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Abbott Laboratories (US)
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Axogen Corporation (US)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Baxter (US)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. LivaNova PLC (UK)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Integra LifeSciences (US)
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Neuronetics Inc. (US)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Nevro Corp (US)
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. NeuroPace Inc. (US)
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global nerve repair and regeneration market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for nerve repair and regeneration are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2335
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
